Our valorization team

Strong interpersonal and communications skills, demonstrated networking capabilities, the ability to build effective relationships, creativity, persistence and a clear understanding of the academic, clinical and business environments is essential to the success of our strategy. Team members contribute their extensive expertise in business development, new company creation, intellectual property, large public funding programmes, international collaborative research, knowledge transfer and communications.

The Valorization Support Team is led by Chris De Jonghe, the Valorization Director, and consists of the following members:

Chris De Jonghe

Chris De Jonghe

Valorization Director



Valorization Director
Alexander Turkin

Alexander Turkin

Business Development

Alexander’s educational background is in physics (BSc) and nanoscience (MSc). His growing fascination for biology and medicine led him to pursue a PhD in biophysics at the University of Groningen. Subsequently, he decided to continue his journey in the Life Sciences branch as a Business Consultant. In this role he was helping both academic and industrial parties to obtain funding, establish partnerships, build consortia, do market research and develop commercialisation plans. At Oncode, Alexander intends to leverage this expertise to support Oncode Researchers with company creation, acquiring funding, establishing collaborations and with other valorization strategies, ultimately creating impact for society.


Business Development
Alina Boca- Eichner

Alina Boca- Eichner

Data Entry Assistant

Alina’s educational background is in psychology (BSc) and occupational health psychology (MSc). Being familiar with statistics and datasets, Alina worked in research assistant and data analysis jobs in both commercial and educational environments. At Oncode, Alina assists the Oncode Valorization Team with all necessary (legal) administrative support by performing data entry and data management tasks. In addition, she is responsible for the prevention officer tasks, given her academic background in psychology.


Data Entry Assistant
Amber Liu

Amber Liu

Business Development



Business Development
Emil Pot

Emil Pot

Business Development

With an educational background in law, Emil has gained over 25 years of experience as a patent attorney and business developer. In his capacity as business development manager at the Flemish Institute for Biotechnology (VIB) he drafted and negotiated licensing, R&D and IP agreements and helped creating two start-up companies. He joined ActoGeniX as general counsel and was responsible for all business development, legal and IP matters. The company raised a total of €45MM in three consecutive financing rounds. Emil is a registered patent attorney, does business development for NLO and acts as CEO of Allero Therapeutics. At Oncode Emil helps to translate fundamental research to the market by developing and executing IP strategies, advising and assisting in company creation and building and maintaining stakeholder relations.


Business Development
Ian Bell

Ian Bell

Business Development

With a background in molecular biology, Ian is an experienced business developer. He has spent 20 years in academic technology transfer at the University of Calgary and University of British Columbia, Canadian provincial and federal governments, industry and as an independent consultant. At Oncode Ian uses his extensive expertise to assess and commercialize life science inventions such as novel therapeutics, antibodies, diagnostics and molecular biology tools; develop IP protection strategies; market and negotiate valorization agreements; create companies and build and maintain academic-industry and stakeholder relations.


Business Development
Koen Verhoef

Koen Verhoef

Technology Development Fund Manager

Koen is a molecular virologist by training, and obtained his PhD from the University of Amsterdam. After postdoctoral research projects at the University of Heidelberg and at Oxford University, he switched gears into technology transfer at the Medical Research Council in London. In 2003 he moved back to the Netherlands and founded the Technology Transfer Office at VU University Medical Centre in Amsterdam. Since 2009 he is leads the Technology Transfer Office of the Netherlands Cancer Institute – Antoni van Leeuwenhoek hospital (NKI-AVL). Koen is an active member of ASTP-Proton, the European professional association for Knowledge Transfer, and served on its Board between 2010 and 2014. At Oncode, Koen manages the Technology Development Fund. This fund is aimed at supporting projects which increase the chances of successful valorisation of Oncode research.


Technology Development Fund Manager
Mariëlle Veldhuizen

Mariëlle Veldhuizen

Paralegal

With more than fifteen years work experience as legal secretary and paralegal in a corporate, commercial environment, Mariëlle provides the Oncode Valorization Team with all necessary le-gal administrative support.


Paralegal
Shobhit Dhawan

Shobhit Dhawan

Fund Manager

Shobhit is the Fund Manager of Oncode Oncology Bridge Fund. Prior to joining Oncode Bridge Fund, he was an early stage investor at UvA/AMC Ventures for 4 years, where he made investments in tech and life science spin offs from the two institutions. Before UvA ventures, Shobhit supported early stage ventures with fundraising and business strategy at ACE incubator in Amsterdam. He trained as a pharmacologist at the University of Oxford and started his drug discovery career at Pfizer UK. Shobhit holds a PhD in immunology from the University of Amsterdam.


Fund Manager
Veerle Fleskens

Veerle Fleskens

Business Development

Veerle is a molecular biologist by training, specialized in molecular immunology. She obtained her PhD from Utrecht University at the University Medical Center Utrecht, followed by postdoctoral research at King’s College London. After several years as a life sciences and business consultant, she joined Oncode Institute as Business Development Manager. Here she supports Oncode Investigators to develop valorization strategies and translate their scientific findings to truly benefit society. Furthermore, she uses her expertise to initiate public-private partnerships and provide support for funding applications to all Oncode Researchers.


Business Development
Yuva Oz

Yuva Oz

Business Development

Over 17 years of experience in Molecular Biology, Yuva completed her MSc. degree at EMBL Heidelberg and conducted her PhD research on the topic of Chromatin and Biomedical Genetics at Hubrecht Institute as a Marie-Curie fellow. Interested in clinical aspects of the research, she joined to oncology specialized clinical research organization SMS-oncology, gaining experience both in clinical trial management (early phase paediatric and adult trials) and Business Development aspects. At Oncode, she is driving the industry engagement programme to enable new alliances and collaborations between Oncode and biopharma to fast-forward research and innovation. Furthermore, working closely with Oncode Investigators, she supports technology, clinical and IP assessments for efficiently translating fundamental research into clinical benefit. She is the founder and designer at Art 4 Science, a scientific visualization – graphic design company.


Business Development
Saharla Ahmed

Saharla Ahmed

Business Development

Saharla has over 10 years’ experience of business development and early-stage financing of life science technologies. Before joining Oncode, Saharla worked as a life sciences and business consultant, helping academic and SME clients to obtain funding, establish partnerships, perform market research and develop commercialisation plans. Prior to that, Saharla worked in the Innovations Division of the Wellcome Trust in the U.K., where she was responsible for manging an international portfolio of translational research programmes, contributing to and designing project and IP strategy, licensing intellectual property and helping to secure venture capital or other external investment. Saharla has a BSc in Genetics and a MSc in Intellectual Property Law, both from Queen Mary University of London.


Business Development